| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 12/30/2004 | US20040265854 Recombinant human SM-11044-binding receptor proteins exhibiting ligand-binding activities, and their uses |
| 12/30/2004 | US20040265839 Gene knockout; gene overexpression; liposomes; fusion proteins; immunoglobulins; FC fragments; glutathione S-transferase (GST) polypeptides |
| 12/30/2004 | US20040265836 Methods for the identification of inhibitors of C4 Long Chain Base Hydroxylase activity in plants |
| 12/30/2004 | US20040265819 Uricosuric regulating action using protein comprising an amino acid sequence represented by SEQ ID NO:1 or an amino acid sequence derived therefrom being capable of transporting uric acid and its analogs; cardiovascular disorders; gout; hypotensive agents; nucleotide sequences; antibodies; modulators |
| 12/30/2004 | US20040265808 Genes involved in osteogenesis, and methods of use |
| 12/30/2004 | US20040265807 Enzymes |
| 12/30/2004 | US20040265799 Human-virus homologous sequences and uses thereof |
| 12/30/2004 | US20040265797 Peptide ligands of the urokinase receptor |
| 12/30/2004 | US20040265792 Agents for treatment of hcv and methods of use |
| 12/30/2004 | US20040265392 Nanoparticles comprising biologically active tnf which is immobilized on the same |
| 12/30/2004 | US20040265386 Gel compositions |
| 12/30/2004 | US20040265369 Compounds that inhibit caspase activity for treating glaucoma |
| 12/30/2004 | US20040265366 Nanocorpuscles having lipid bilayer with biliar salt and phospholipid and metallothionein in the interior; nervous system and neurodegenerative disorders; Alzheimer*s and Parkinson*s disease; multiple sclerosis, amyotrophic lateral sclerosis, viral and bacterial meningitis, spongiform encephalopathy |
| 12/30/2004 | US20040265350 Ceramic carrier comprising interconnected skeleton of scaffolding and struts having pores; low density; time-release agents; fibroblast-, or transforming growth factors; bone morphogenic proteins, somatotrophin; antibiotics, vitamins, proteins, hormones, radiopacity agents |
| 12/30/2004 | US20040265342 Desensitizing a patient to polypeptide allergen by administering a peptide derived from allergen to induce a late phase response in an individual who possesses major histocompatibility complex Class II molecule; immunotherapy; vaccines |
| 12/30/2004 | US20040265336 Multivalent vaccination using recombinant adenovirus |
| 12/30/2004 | US20040265321 A dimeric fusion protein having two identical polypeptide chains, each chain wtih an extracellular region of an activating Fc gamma R containing an Fc binding site, joined to a molecule that binds an Fc gamma Rn; dimeric fusion protein specifically binds an immune complex |
| 12/30/2004 | US20040265320 Administering a compound selected from 3-O-(3',3'-dimethylsuccinyl) betulinic acid, 3-O-(3',3'-dimethylsuccinyl) betulin, 3-O-(3',3'-dimethylglutaryl) betulin, 3-O-(3',3'-dimethylsuccinyl) dihydrobetulinic acid, 3-O-(3',3'-dimethylglutaryl) betulinic acid, (3',3'-dimethylglutaryl) dihydrobetulinic acid |
| 12/30/2004 | US20040265317 Methods and compositions useful for inhibition of angiogenesis |
| 12/30/2004 | US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative |
| 12/30/2004 | US20040265314 Soluble CLCA-1 and antagonists to CLCA-1 |
| 12/30/2004 | US20040265311 Methods for diagnosing and treating hemostatic disorders by modulating P-selectin activity |
| 12/30/2004 | US20040265310 Novel prostate-restricted gene expressed in prostate cancer |
| 12/30/2004 | US20040265309 Method of tumor regression with VEGF inhibitors |
| 12/30/2004 | US20040265308 Prevention and treatment of amyloidogenic disease |
| 12/30/2004 | US20040265306 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4 |
| 12/30/2004 | US20040265305 Inhibiting fibrosis, scleroderma, sarcoidosis, ankylosing spondilitis; monitoring the efficacy of the treatment; bioassay |
| 12/30/2004 | US20040265302 Preventing airway mucus production by administration of EGF-R antagonists |
| 12/30/2004 | US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target |
| 12/30/2004 | US20040265298 Denaturing by first dissolving the protein with a chaotroph at high pH, refolding by dilution in the presence of reduced concentrations of chaotroph at low pH; forming a stable solution; purification; for the treatment of thrombosis |
| 12/30/2004 | US20040265297 Administering to a patient an enzyme that cleaves and digest chondroitin sulfate proteoglycan, against integrins containing chondroitin sulfate proteoglycans expressed on the surface of the cells; chondroitinase or hyaluronidase; antiinflammation |
| 12/30/2004 | US20040265296 Use of antimicrobial proteins and peptides for the treatment of otitis media and paranasal sinusitis |
| 12/30/2004 | US20040265294 Systems and methods for opening obstructed biological conduits |
| 12/30/2004 | US20040265285 Deleting lympocytes and reactivating thymus via CD34-antigens and/or leutininzing hormone releasing hormone agonists (sex steroids); for alleviation of autoimmune diseases and allergies |
| 12/30/2004 | US20040265283 Hepatocyte growth factor gene as an active therapeutic agent; biodrugs; Parkinson's disease, Alzheimer's disease, spinal cord injury, diabetic peripheral neuritis, and ischemic cerebrovascular disorders (cerebral infarction, cerebral haemorrhage) |
| 12/30/2004 | US20040265280 Phoma sp. SANK 13899 (FERM BP-6851) strain; produce fungicide through fermentation process; obtained from a soil sample collected in Chichi-island, Ogasawara-mura, Tokyo |
| 12/30/2004 | US20040265277 Agents for treating malignant diseases using the protein YB-1 |
| 12/30/2004 | US20040265273 gene therapy; nucleic acid sequence encoding an amino terminal fragment of urokinase that comprises and epidermal growth factor-like domain; antimetastasis; murine urokinase ATF expressed by tumor cells in an athymic murine model unexpectedly effectively inhibits tumorigenicity |
| 12/30/2004 | US20040265270 recombinant; Interferons; stabilized with a polyol, a non-reducing sugar or a amino acid; acetate buffer, albumin; mannitol, saccharose and glycine; storage stability |
| 12/30/2004 | US20040265268 cell growth enhancers to increase growth rate of skin cells, nutrients to support log phase growth of skin cells, extracellular matrix proteins, stimulators of extracellular matrix proteins, penetration enhancers; wound healing |
| 12/30/2004 | US20040265238 Inhalable formulations for treating pulmonary hypertension and methods of using same |
| 12/30/2004 | US20040265230 Compositions and methods for diagnosing and treating colon cancers |
| 12/30/2004 | DE20221079U1 New expression vector for producing annexin V, useful as anticoagulant, includes kanamycin resistance gene, also Escherichia coli containing the vector |
| 12/29/2004 | WO2004113562A1 Method for assaying lkb1 phosphorylation activity |
| 12/29/2004 | WO2004113552A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 12/29/2004 | WO2004113535A1 Synuclein mutant having anticoagulant effect |
| 12/29/2004 | WO2004113533A1 LIVER X RECEPTOR α SPLICING VARIANT PROTEIN, GENE CODING FOR THE SAME AND USE THEREOF |
| 12/29/2004 | WO2004113523A1 Granzyme b/golgin-160 interaction inhibitor |
| 12/29/2004 | WO2004113522A1 New biological entities and the pharmaceutical or diagnostic use thereof |
| 12/29/2004 | WO2004113521A1 New biological entities and the use thereof |
| 12/29/2004 | WO2004113513A2 Methods and compositions for modulating stem cell growth and differentiation |
| 12/29/2004 | WO2004113500A2 B7s1: an immune modulator |
| 12/29/2004 | WO2004113386A2 Modified hirudin proteins and t-cell epitopes in hirudin |
| 12/29/2004 | WO2004113384A1 Use of a vegf receptor gene or gene product |
| 12/29/2004 | WO2004113383A2 Pegylated soluble gp130-dimers useful as a medicament |
| 12/29/2004 | WO2004113381A1 Relaxin superfamily peptide analogues |
| 12/29/2004 | WO2004113378A2 Control of lactation and peptides therefore |
| 12/29/2004 | WO2004113375A2 Antimicrobial compositions and uses thereof |
| 12/29/2004 | WO2004113368A1 Cyclic lipopeptides |
| 12/29/2004 | WO2004113367A1 Peptide having apoptosis-inhibiting activity |
| 12/29/2004 | WO2004113365A2 Hepatitis c serine protease tri-peptide inhibitors |
| 12/29/2004 | WO2004113363A2 Dipeptide transglutaminase inhibitors and methods of using the same |
| 12/29/2004 | WO2004113350A1 Cross-linked glycopeptide - cephalosporin antibiotics |
| 12/29/2004 | WO2004112843A2 Odor control compositions and methods |
| 12/29/2004 | WO2004112833A1 Epitope composition for sublingual, buccal or enteric administration prepared by hydrolysis of antigenic structures with chymotrypsin |
| 12/29/2004 | WO2004112830A2 Clostridial toxins for treating eye disorders |
| 12/29/2004 | WO2004112828A1 Liquid composition of factor vii polypeptides |
| 12/29/2004 | WO2004112827A1 Sustained-release fine granular preparation of human growth hormone and process for producing the same |
| 12/29/2004 | WO2004112826A1 Freeze-dried fsh / lh formulations |
| 12/29/2004 | WO2004112824A1 Hip/pap polypeptide composition for use in liver regeneration and for the prevention of liver failure |
| 12/29/2004 | WO2004112822A1 Synthetic peptide combinations and methods for the production thereof |
| 12/29/2004 | WO2004112821A1 Remedies for diseases with hypermyotonia |
| 12/29/2004 | WO2004112820A2 Peptides and peptidomimetics having immune-modulating, anti-inflammatory, and anti-viral activity |
| 12/29/2004 | WO2004112804A1 Agent for inhibiting membrane virus reproduction, method for the production thereof, pharmaceutical composition and method for inhibiting viral infections |
| 12/29/2004 | WO2004112803A1 Methods of managing the symptoms of premenstrual syndrome |
| 12/29/2004 | WO2004112795A1 Ltb4 compositions for treating tract infections |
| 12/29/2004 | WO2004112763A2 Inhibition of protein kinase c-mu (pkd) as a treatment for cardiac hypertrophy and heart failure |
| 12/29/2004 | WO2004112752A1 Method of preparing mixed formulation of sustained release microspheres by continuous one-step process |
| 12/29/2004 | WO2004112726A2 Methods and compositions for controlling appetite and modulating insulin sensitivity |
| 12/29/2004 | WO2004112724A2 Compositions for and methods for treating hiv |
| 12/29/2004 | WO2004112717A2 Conjugate for the specific targeting of anticancer agents to cancer cells and production thereof |
| 12/29/2004 | WO2004112697A2 Immune enhancing composition containing lactoferrin |
| 12/29/2004 | WO2004112693A2 Tissue protective cytokines with an extended therapeutic window |
| 12/29/2004 | WO2004112691A2 Interferon gamma therapies for idiopathic pulmonary fibrosis |
| 12/29/2004 | WO2004112572A2 Monitoring immunologic, hematologic and inflammatory diseases |
| 12/29/2004 | WO2004112498A1 Methods for hyperthyroidism in a cat and composition comprising limited iodine |
| 12/29/2004 | WO2004112482A2 Biological active coating components, coatings, and coated surfaces |
| 12/29/2004 | WO2004101608A3 Apo2l (trail) receptor binding peptides and uses thereof |
| 12/29/2004 | WO2004099672A3 Non-catalytic combustor for reducing nox emissions |
| 12/29/2004 | WO2004099244A3 Immunogenic human tnf alpha analogues with reduced cytotoxicity and methods of their preparation |
| 12/29/2004 | WO2004090121A3 Stem cells having increased sensitivity to a chemoattractant and methods of generating and using same |
| 12/29/2004 | WO2004087067A3 Treatment of aspergillus infections with thymosin alpha 1 |
| 12/29/2004 | WO2004084942A3 Methods and means to suppress symptoms of an allergic disease by inhibiting the glucocorticoid-induced tumor necrosis factor receptor (gitr or tnfrsf18) |
| 12/29/2004 | WO2004084932A3 Use of clusterin for the treatment and/or prevention of peripheral neurological diseases |
| 12/29/2004 | WO2004082640A3 Human serum albumin conjugates with therapeutic compounds |
| 12/29/2004 | WO2004081043A3 Baff mutants with at least one amino acid substitution and methods of their production |
| 12/29/2004 | WO2004078921A3 Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes |
| 12/29/2004 | WO2004078097A3 Modified aerolysin linked to a lung cancer binding agent and methods of use for treating lung cancer |
| 12/29/2004 | WO2004078061A3 Methods and kits for maintaining pregnancy, treating follicular cysts, and synchronizing ovulation using luteinizing hormone |
| 12/29/2004 | WO2004076657A3 Cell and enzyme compositions for modulating bile acids, cholesterol and triglycerides |